The FDA's latest DTC study: Heavy ad rotation on TV

People love to make fun of drug ads. They love to complain about certain ads airing in prime time (erectile dysfunction drugs, for instance). How do they react to seeing the same TV ad over and over again? The FDA wants to know, so it's considering a study to determine whether consumers get a different idea about a particular drug when they view an ad multiple times compared with those who see it only once. Report

Suggested Articles

​​​​​​​Baseball and allergy season are in full swing, and Houston Astros pitcher Justin Verlander knows both. He stars in GSK's new seasonal push.

PhRMA’s latest round of drug-cost ads defends a drugmaker favorite—the copay coupon—against new payer programs designed to thwart it.

Researchers plan to tackle issues related to accelerated approval, risk comprehension for new drugs, scientific versus promotional claims and TV ads.